Endometrial bleeding during hormone therapy: The effect of progestogens

Maturitas

Volumn 57, Issue 1, 2007, Pages 71-76

  Archer, David F ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Endometrial bleeding; Hormone therapy; Progestogens

Indexed keywords

ESTROGEN; GESTAGEN; METALLOPROTEINASE; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CONTRACEPTION; DATA ANALYSIS; ENDOMETRIAL DISEASE; ENDOMETRIUM; EVALUATION; HEMOSTASIS; HUMAN; MEDICAL LITERATURE; MENSTRUATION; NATURAL KILLER CELL; PATIENT MONITORING; VAGINA BLEEDING;

DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIUM; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; METRORRHAGIA; POSTMENOPAUSE; PROGESTINS;

EID: 34247142290     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.02.022     Document Type: Article

References (45)

1. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 3 (2002) 321-333
2. Chlebowski R.T., Hendrix S.L., Langer R.D., et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 289 24 (2003) 3243-3253
3. Manson J.E., Hsia J., Johnson K.C., et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349 6 (2003) 523-534
4. Gordon T., Kannel W.B., Hjortland M.C., and McNamara P.M. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 89 2 (1978) 157-161
5. Brinton L.A., Hoover R., and Fraumeni Jr. J.F. Interaction of familial and hormonal risk factors for breast cancer. J Natl Cancer Inst 69 4 (1982) 817-822
6. Ketcham A.S., and Sindelar W.F. Risk factors in breast cancer. Prog Clin Cancer 6 (1975) 99-114
7. Archer D.F. The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women. Menopause 8 4 (2001) 245-251
8. Archer D.F. Neoplasia of the female reproductive tract: effects of hormone therapy. Endocrine 24 3 (2004) 259-263
9. ACOG Task Force on Hormone Therapy. Ovarian, endometrial, and colorectal cancers. Obstet Gynecol 104 4 Suppl. (2004) 77S-84S
10. Anderson G.L., Judd H.L., Kaunitz A.M., et al. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA 290 13 (2003) 1739-1748
11. Hulley S., Furberg C., Barrett-Connor E., et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288 1 (2002) 58-66
12. The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 275 5 (1996) 370-375
13. Lethaby A., Suckling J., Barlow D., Farquhar C.M., Jepson R.G., and Roberts H. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. Cochrane Database Syst Rev 3 (2004) CD000402
14. Lethaby A., Farquhar C., Sarkis A., Roberts H., Jepson R., and Barlow D. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. Cochrane Database Syst Rev 2 (2000) CD000402
15. Lacey Jr. J.V., Brinton L.A., Lubin J.H., Sherman M.E., Schatzkin A., and Schairer C. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 14 7 (2005) 1724-1731
16. Strom B.L., Schinnar R., Weber A.L., et al. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. Am J Epidemiol 164 8 (2006) 775-786
17. Weiderpass E., Adami H.O., Baron J.A., et al. Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst 91 13 (1999) 1131-1137
18. Anderson G.L., Limacher M., Assaf A.R., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 14 (2004) 1701-1712
19. Archer D.F., Pickar J.H., and Bottiglioni F. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group. Obstet Gynecol 83 5 Pt 1 (1994) 686-692
20. Archer D.F., Dorin M., Lewis V., Schneider D.L., and Pickar J.H. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding. Fertil Steril 75 6 (2001) 1080-1087
21. Archer D.F., Dorin M.H., Heine W., Nanavati N., and Arce J.C. Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate. Endometrium Study Group. Obstet Gynecol 94 3 (1999) 323-329
22. Rowan J.P., Simon J.A., Speroff L., and Ellman H. Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 μm) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials. Clin Ther 28 6 (2006) 921-932
23. Simon J.A., Liu J.H., Speroff L., Shumel B.S., and Symons J.P. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy. Am J Obstet Gynecol 188 1 (2003) 92-99
24. Speroff L., Rowan J., Symons J., Genant H., and Wilborn W. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial. JAMA 276 17 (1996) 1397-1403
25. Pickar J.H., and Archer D.F. Is bleeding a predictor of endometrial hyperplasia in postmenopausal women receiving hormone replacement therapy? Menopause Study Group (United States, Italy, Netherlands, Switzerland, Belgium, Germany, and Finland. Am J Obstet Gynecol 177 5 (1997) 1178-1183
26. Pickar J.H., Bottiglioni F., and Archer D.F. Amenorrhea frequency with continuous combined hormone replacement therapy: a retrospective analysis. Menopause Study Group. Climacteric 1 2 (1998) 130-136
27. Krikun G., Schatz F., Taylor R., et al. Endometrial endothelial cell steroid receptor expression and steroid effects on gene expression. J Clin Endocrinol Metab 90 3 (2005) 1812-1818
28. Critchley H.O., Brenner R.M., Henderson T.A., et al. Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab 86 3 (2001) 1370-1378
29. Press M.F., Udove J.A., and Greene G.L. Progesterone receptor distribution in the human endometrium. Analysis using monoclonal antibodies to the human progesterone receptor. Am J Pathol 131 1 (1988) 112-124
30. Lecce G., Meduri G., Ancelin M., Bergeron C., and Perrot-Applanat M. Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells. J Clin Endocrinol Metab 86 3 (2001) 1379-1386
31. Charnock-Jones D.S., Macpherson A.M., Archer D.F., et al. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. Hum Reprod 15 Suppl. 3 (2000) 85-95
32. Hickey M., Dwarte D., and Fraser I.S. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding. Hum Reprod 15 7 (2000) 1509-1514
33. Lockwood C.J., Runic R., Wan L., Krikun G., Demopolous R., and Schatz F. The role of tissue factor in regulating endometrial haemostasis: implications for progestin-only contraception. Hum Reprod 15 Suppl. 3 (2000) 144-151
34. Hickey M., Pillai G., Higham J.M., et al. Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding. Hum Reprod 18 5 (2003) 1100-1106
35. Mirkin S., Navarro F., and Archer D.F. Hormone therapy and endometrial angiogenesis. Climacteric 6 4 (2003) 273-277
36. Vincent A.J., and Salamonsen L.A. The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives. Hum Reprod 15 Suppl. 3 (2000) 135-143
37. Vincent A.J., Zhang J., Ostor A., et al. Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding?. Hum Reprod 17 5 (2002) 1189-1198
38. Hickey M., Crewe J., Mahoney L.A., Doherty D.A., Fraser I.S., and Salamonsen L.A. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors. J Clin Endocrinol Metab 91 8 (2006) 3189-3198
39. Hickey M., Crewe J., Goodridge J.P., et al. Menopausal hormone therapy and irregular endometrial bleeding: a potential role for uterine natural killer cells?. J Clin Endocrinol Metab 90 10 (2005) 5528-5535
40. Chegini N., Luo X., Pan Q., Rhoton-Vlasak A., and Archer D.F. Endometrial expression of epithelial neutrophil-activating peptide-78 during the menstrual cycle or in progestin-only contraceptive users with breakthrough bleeding and the influence of doxycycline therapy. Hum Reprod (2006)
41. Li R., Luo X., Pan Q., et al. Doxycycline alters the expression of inflammatory and immune-related cytokines and chemokines in human endometrial cells: implication in irregular uterine bleeding. Hum Reprod 21 10 (2006) 2555-2563
42. Whitehead M.I., King R.J., McQueen J., and Campbell S. Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy. J R Soc Med 72 5 (1979) 322-327
43. Whitehead M.I., Townsend P.T., Pryse-Davies J., Ryder T.A., and King R.J. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 305 27 (1981) 1599-1605
44. Archer D.F., Lobo R.A., Land H.F., and Pickar J.H. A comparative study of transvaginal uterine ultrasound and endometrial biopsy for evaluating the endometrium of postmenopausal women taking hormone replacement therapy. Menopause 6 3 (1999) 201-208
45. Goldstein S.R. The endometrial echo revisited: have we created a monster?. Am J Obstet Gynecol 191 4 (2004) 1092-1096